Abstract Title:

Neuroprotective Effect of Cinnamaldehyde on Secondary Brain Injury After Traumatic Brain Injury in a Rat Model.

Abstract Source:

World Neurosurg. 2021 Sep ;153:e392-e402. Epub 2021 Jul 2. PMID: 34224887

Abstract Author(s):

Pınar Kuru Bektaşoğlu, Türkan Koyuncuoğlu, Dilan Demir, Gizem Sucu, Dilek Akakın, İrem Peker Eyüboğlu, Meral Yüksel, Erhan Çelikoğlu, BerrakÇ Yeğen, Bora Gürer

Article Affiliation:

Pınar Kuru Bektaşoğlu


OBJECTIVE: The aim of this study was to investigate the possible neuroprotective effects of cinnamaldehyde (CA) on secondary brain injury after traumatic brain injury (TBI) in a rat model.

METHODS: Rats were randomly divided into 4 groups: control (n = 9), TBI (n = 9), vehicle (0.1% Tween 80; n = 8), and CA (100 mg/kg) (n = 9). TBI was induced by the weight-drop model. In brain tissues, myeloperoxidase activity and the levels of luminol-enhanced and lucigenin-enhanced chemiluminescence were measured. Interleukin 1β, interleukin 6, tumor necrosis factor α, tumor growth factor β, caspase-3, and cleaved caspase-3 were evaluated with an enzyme-linked immunosorbent assay method. Brain injury was histopathologically graded after hematoxylin-eosin staining. Y-maze and novel object recognition tests were performed before TBI and within 24hours of TBI.

RESULTS: Higher myeloperoxidase activity levels in the TBI group (P<0.001) were suppressed in the CA group (P<0.05). Luminol-enhanced and lucigenin-enhanced chemiluminescence, which were increased in the TBI group (P<0.001, for both), were decreased in the group that received CA treatment (P<0.001 for both). Compared with the increased histologic damage scores in the cerebral cortex and dentate gyrus of the TBI group (P<0.001), scores of the CA group were lower (P<0.001). Decreased number of entries and spontaneous alternation percentage in the Y-maze test of the TBI group (P<0.05 and P<0.01, respectively) were not evident in the CA group.

CONCLUSIONS: CA has shown neuroprotective effects by limiting neutrophil recruitment, suppressing reactive oxygen species and reducing histologic damage and acute hippocampal dysfunction.

Study Type : Animal Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.